Your session is about to expire
← Back to Search
Meditation for Brain Health (BLISS Trial)
N/A
Recruiting
Led By Balachundar Subramaniam, MD, MPH
Research Sponsored by Beth Israel Deaconess Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if a 21-minute meditation called Shambhavi Mahamudra Kriya can improve brain health and overall well-being. The study targets people interested in better brain function and reduced stress. The meditation uses specific breathing and meditation techniques to help achieve these benefits. Shambhavi Mahamudra Kriya is a multicomponent breath-based yogic practice that has been shown to reduce perceived stress and improve general well-being after regular practice.
Who is the study for?
This trial is for Massachusetts residents aged 20-65 who can understand the study and consent to participate. It's not for pregnant individuals, non-English speakers, those with less than a high school education, or anyone in another study that could affect results. People with recent substance abuse, significant visual impairment, history of certain neurological issues or psychiatric illnesses are also excluded.
What is being tested?
The trial tests if Shambhavi Mahamudra Kriya—a 21-minute meditation practice—can improve brain health and cognitive function. Participants will regularly perform this meditation to see its effects on their mental and physiological state.
What are the potential side effects?
Meditation practices like Shambhavi Mahamudra Kriya typically have minimal side effects; however, some individuals may experience discomfort during sitting, mild headaches or fatigue post-meditation. Rarely it might trigger emotional distress if underlying psychological conditions are present.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at baseline and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Frontal Midline Theta Power after 6 Months of Daily Meditation Practice
Change in Gamma Slope Index (GSI) after 6 Months of Daily Meditation
Secondary study objectives
Change in Brain Connectivity after 6 Months of Daily Meditation Practice
Change in Brain cortical thickness after 6 Months of Daily Meditation Practice
Brain
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Wellness and Meditation-Based InterventionExperimental Treatment1 Intervention
Shambhavi Mahamudra Kriya: a multi-component 21-minute meditation that incorporates a combination of different breathing patterns and meditative components.
Group II: ControlActive Control1 Intervention
Control Group: selected to be age, gender and education level matched with the intervention group and will be asked to continue their daily routine while completing surveys at each timepoint.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Meditation practices like Shambhavi Mahamudra Kriya influence brain activity and neuroplasticity by promoting relaxation, reducing stress, and enhancing cognitive function. These practices typically involve focused attention, deep breathing, and mindfulness, which can lead to changes in brain regions associated with attention, emotion regulation, and self-awareness.
The increased neuroplasticity helps in forming new neural connections, improving mental flexibility, and resilience. For patients, these mechanisms are crucial as they can lead to better management of stress, anxiety, and overall mental well-being, contributing to improved quality of life.
Application of Solution-Focused Brief Therapy (SFBT) in individuals after stroke.A randomised controlled trial of a brief online mindfulness-based intervention.
Application of Solution-Focused Brief Therapy (SFBT) in individuals after stroke.A randomised controlled trial of a brief online mindfulness-based intervention.
Find a Location
Who is running the clinical trial?
Beth Israel Deaconess Medical CenterLead Sponsor
861 Previous Clinical Trials
12,932,746 Total Patients Enrolled
2 Trials studying Meditation
42 Patients Enrolled for Meditation
Balachundar Subramaniam, MD, MPHPrincipal InvestigatorBeth Israel Deaconess Medical Center
3 Previous Clinical Trials
529 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been practicing meditation regularly for the last 6 months.I am currently being treated for chronic pain.I am currently taking medication to improve my memory or thinking.I have had a stroke or aneurysm in the last 5 years.I am between 20 and 65 years old.I have major difficulty seeing.I have never had dementia, Parkinson's, Alzheimer's, Huntington's, brain tumors, or brain surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Wellness and Meditation-Based Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.